First Command Advisory Services’s Zimmer Biomet ZBH Stock Holding History

First Command Advisory Services’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,535	Closed	-$187K	–	675
2023 Q4	$187K	Hold	1,535	–	–	﹤0.01%	152
2023 Q3	$172K	Buy	+1,535	New	+$195K	﹤0.01%	151

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Command Advisory Services's ZBH Position: Q1 2024 in Review

First Command Advisory Services sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 1,535 shares — an estimated $187K sold.

First Command Advisory Services first reported a position in ZBH in Q3 2023 and held it in 2 quarters. The position peaked at $187K in Q4 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

First Command Advisory Services reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
First Command Advisory Services sold 1,535 Zimmer Biomet shares in Q1 2024, an estimated $187K.
First Command Advisory Services first reported a position in Zimmer Biomet in Q3 2023 and held it in 2 quarters.
First Command Advisory Services's Zimmer Biomet position peaked at $187K in Q4 2023.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on First Command Advisory Services's 13F filing for Q1 2024, filed 2 May 2024.